SAR446597 clinical trials

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

This study is testing a new, one-time eye injection for people with Geographic Atrophy (GA), a severe form of age-related macular degeneration (AMD). Researchers want to see if it's safe and helps improve or maintain vision. It involves a single treatment followed by long-term check-ups.